Acquisition, Cross border deal, Private equity deal – Secondary
Mipharm, a Milan-based company recognized among the Italian leaders in the CDMO (Contract Development and Manufacturing Organization) industry, today saw 100% of its capital changing hands: Mandarin Capital Partners II (MCP) sold its stake to the private equity fund Alto Partners, together with the shares held by the President and CEO Maurizio Silvestri (through Euteam), Cassiopea Partners and other managers.
Click here to read the press release
Target – MIPHARM S.P.A.
Seller – Mandarin Investment Management S.A
Seller – Maurizio Silvestri (Private Investor)
Seller – CASSIOPEA PARTNERS SR
